bioAffinity Technologies, Inc. Property, Plant and Equipment, Gross
bioAffinity Technologies, Inc. (BIAF) had Property, Plant and Equipment, Gross of $1.02 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-07
- 2026-06-30: Property, Plant and Equipment, Gross $1.02M.
- 2026-03-31: Property, Plant and Equipment, Gross $952.83K.
- 2025-12-31: Property, Plant and Equipment, Gross $969.84K.
- 2025-09-30: Property, Plant and Equipment, Gross $969.84K.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $1.02M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $952.83K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $969.84K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $969.84K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $975.85K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $962.42K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $911.64K 10-K · filed 2026-03-16 |
| 2024-09-30 | $911.64K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $902.22K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $873.94K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $831.76K 10-K · filed 2025-03-31 |
| 2023-09-30 | $848.11K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $519.79K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $515.93K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $483.62K 10-K · filed 2024-04-01 |
| 2022-09-30 | $263.63K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $263.63K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |